XN demonstrates a dual anti-cancer effect by effectively suppressing NF-κB activity and IL1β expression in MCF7 cells and endothelial cells, impacting both tumor cells and angiogenesis [163]. The gene discussed is NFKB1; the disease is neoplasm.